KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Non-Current Deferred Tax Liability (2019 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Non-Current Deferred Tax Liability for 8 consecutive years, with $161.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 17.29% to $161.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $161.5 million, a 17.29% increase, with the full-year FY2025 number at $161.5 million, up 17.29% from a year prior.
  • Non-Current Deferred Tax Liability was $161.5 million for Q4 2025 at Supernus Pharmaceuticals, up from $981000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $161.5 million in Q4 2025 to a low of $981000.0 in Q1 2025.
  • A 5-year average of $50.4 million and a median of $39.8 million in 2023 define the central range for Non-Current Deferred Tax Liability.
  • Peak YoY movement for Non-Current Deferred Tax Liability: skyrocketed 451.6% in 2024, then tumbled 94.97% in 2025.
  • Supernus Pharmaceuticals' Non-Current Deferred Tax Liability stood at $85.4 million in 2021, then plummeted by 41.64% to $49.8 million in 2022, then tumbled by 49.88% to $25.0 million in 2023, then surged by 451.6% to $137.7 million in 2024, then increased by 17.29% to $161.5 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Non-Current Deferred Tax Liability are $161.5 million (Q4 2025), $981000.0 (Q1 2025), and $137.7 million (Q4 2024).